Hualan Biological Engineering Inc.

Hualan Biological Engineering Inc. is a leading biotechnology research company dedicated to advancing human healthcare. Founded in 1992, Hualan Biological Engineering Inc. focuses on the research, development, production, and commercialization of human blood products, vaccines, monoclonal antibodies, and genetic recombination biologics. With a commitment to innovation and quality, Hualan Bio is recognized as a national innovation-based pilot enterprise.

Hualan Bio has achieved significant milestones, including being the first Chinese company to obtain GMP certification for plasma products and the first listed company in China for plasma products. Furthermore, Hualan Biological Engineering Inc. was the first company to manufacture the H1N1 influenza vaccine on a global scale and the first Chinese manufacturer whose influenza vaccine passed WHO pre-qualification. Located in Xinxiang, Henan 453000, CN, Hualan Bio adheres to the highest standards, holding “ISO9000” (Quality), “ISO14000” (Environment), and “GBT28000” (Occupation health) management system certifications.

Hualan Bio has expanded its reach with more than 30 subsidiaries and industrial investments across multiple regions. The company's market share and coverage rate of major products rank at the forefront of the industry, with products exported to Southeast Asia and Latin America. Hualan Biological Engineering Inc. invites enterprises in biologics R&D, manufacturing, and marketing for sincere cooperation and mutual development. We encourage the management team at Hualan Bio to create a customized and exclusive company showcase and product listing on our platform.